C609T Polymorphism of NADPH Quinone Oxidoreductase 1 Correlates Clinical Hematological Toxicities in Lung Cancer Patients Treated with Amrubicin
Main Authors: | Misato Nagata, Tatsuo Kimura, Tomohiro Suzumura, Yukimi Kira, Toshiyuki Nakai, Kanako Umekawa, Hidenori Tanaka, Kuniomi Matsuura, Shigeki Mitsuoka, Naruo Yoshimura, Takako Oka, Shinzoh Kudoh, Kazuto Hirata |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2013-02-01
|
Series: | Clinical Medicine Insights: Oncology |
Online Access: | http://la-press.com/c609t-polymorphism-of-nadph-quinone-oxidoreductase-1-correlates-clinic-article-a3535 |
Similar Items
-
C609T polymorphism of NADPH Quinone Oxidoreductase 1 Correlates Clinical Hematological Toxicities in Lung Cancer Patients Treated with Amrubicin
by: Misato Nagata, et al.
Published: (2013-01-01) -
Reduced CYP2D6 function is associated with gefitinib-induced rash in patients with non-small cell lung cancer
by: Suzumura Tomohiro, et al.
Published: (2012-12-01) -
Review of the Management of Relapsed Small-Cell Lung Cancer with Amrubicin Hydrochloride
by: Tatsuo Kimura, et al.
Published: (2011-01-01) -
Lack of association between NADPH quinone oxidoreductase 1 (NQO1) gene C609T polymorphism and lung cancer: a case-control study and a meta-analysis.
by: Shujie Guo, et al.
Published: (2012-01-01) -
Correlation between NAD(P)H: quinone oxidoreductase 1 C609T polymorphism and increased risk of esophageal cancer: evidence from a meta-analysis
by: Jingfang Diao, et al.
Published: (2017-01-01)